Application and Revision of Montreal Cognitive Assessment in Chinese Retirees

Application and Revision of Montreal Cognitive Assessment in Military Retirees With Mild Cognitive Impairment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02483754

Acronym

ARMOCA

Enrollment

304

Registered

2015-06-29

Start date

2011-01-31

Completion date

2014-03-31

Last updated

2017-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Brief summary

The study was designed to employ MOCA to screen mild cognitive impairment (MCI) in military retirees and to analyze the associated risk factors. As such, MOCA was revised to be validated for the Chinese context.

Detailed description

Three hundred and four retired military cadres were investigated using a random cluster sampling technique including personal information, prevalence, MOCA scale, and related neuropsychiatry scale. Thirty retirees were random chosen and tested again with the revised MOCA scale one month later.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* aged \>=60 years old retired military cadres lived in Xian,Shaanxi,China questionnaires completed

Exclusion criteria

* deaf-mute

Design outcomes

Primary

Measure	Time frame	Description
MCI occurrence rate	up to 8 months	Three hundred and four retired military cadres from 9 Xi'an military sanatoria were investigated，assessed up to 8 months

Outcome results